UK company Reaction Engines is developing its Synergetic Air-Breathing Rocket Engine (SABRE), which could fly in space at Mach 25 and cut UK-Australia flight times to ‘as little as four hours’.
Month: October 2019
‘Revolution’ in prostate cancer care as off-label breast cancer drug doubles survival
A breast cancer drug has been used to double the survival of men with advanced prostate cancer, becoming the first successful precision medicine for the disease.
Doctors at the Royal Marsden Hospital who conducted the trial say the results amount to a “revolution” in prostate cancer care.
They conducted genetic testing on more than 4,400 patients to identify those with one or more of 15 types of DNA fault.